Nomura Adjusts Shenzhen Mindray Bio-Medical's Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy
Nomura Adjusts Shenzhen Mindray Bio-Medical's Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy
野村將深圳邁瑞生物醫療的目標股價從423.39元調整至441.20元人民幣，維持買入狀態
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間